• Western blot analysis of various lysates, using CLDN11 antibody (STJ23156) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.

Anti-CLDN11 antibody (26-207) (STJ23156)

SKU:
STJ23156

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CLDN11 (26-207) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.05% Proclin300, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CLDN11
Gene ID: 5010
Uniprot ID: CLD11_HUMAN
Immunogen Region: 26-207
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 26-207 of human CLDN11 (NP_005593.2).
Immunogen Sequence: STNDWVVTCGYTIPTCRKLD ELGSKGLWADCVMATGLYHC KPLVDILILPGYVQACRALM IAASVLGLPAILLLLTVLPC IRMGQEPGVAKYRRAQLAGV LLILLALCALVATIWFPVCA HRETTIVSFGYSLYAGWIGA VLCLVGGCVILCCAGDAQAF GENRFYYTAGSSSPTHAKSA HV
Function Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity.
Protein Name Claudin-11
Oligodendrocyte-Specific Protein
Database Links Reactome: R-HSA-420029
Cellular Localisation Cell Junction
Tight Junction
Cell Membrane
Multi-Pass Membrane Protein
Alternative Antibody Names Anti-Claudin-11 antibody
Anti-Oligodendrocyte-Specific Protein antibody
Anti-CLDN11 antibody
Anti-OSP antibody
Anti-OTM antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance